Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Jon Congleton Net Worth & Insider Trades

Jon Congleton - President and CEO, Nivalis Therapeutics, Inc

As of September 14, 2016

What is Jon Congleton's Net Worth?

The current estimated net worth of Nivalis Therapeutics, Inc's President and CEO, Jon Congleton, is estimated to be about $6.34M . Jon Congleton owns about 20,000 units of Nivalis Therapeutics, Inc common stock. In the last year at Nivalis Therapeutics, Inc, Jon Congleton has sold an estimated value of $0 worth.

What is Jon Congleton's Past Insider Trading?

Jon Congleton's largest purchase order was 5,000 units , worth over $40.5K on December 14, 2015. In total, Jon Congleton has made about 6 transactions over a year of their time at Nivalis Therapeutics, Inc. Jon Congleton usually trades in September and March, with the busiest year in 2016. The most recent transaction was a purchase order of 5,000 units , worth over $19.34K on June 17, 2016.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Jon Congleton

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Jon Congleton's' Mailing Address?

  • Mailing address is 3122 Sterling Circle, Suite 200 Boulder CO 80301 CO

What are Nivalis Therapeutics, Inc's Past Insider Trades?

Nivalis Therapeutics, Inc's most recent insider trade came on June 22, 2017 by Pil Partners Bvf, Fund Value Biotechnology, Biotechnology Value Fund Ii Lp, Biotechnology Value Trading Fund Os Lp, Bvf Partners Os Ltd, Incil Bvf and Mark Lampert who bought 17,806 units worth $40.06K . In the last 2 years, insiders at Nivalis Therapeutics, Inc have sold an estimated value of $89.23K and bought an estimated value of $12.58M worth of shares. Insider trading is most common in September, with the busiest year in 2015. The most active traders at the company are Robert Conway, Director,  Jon Congleton, President and CEO,  and Biotechnology Value Fund Ii Lp .

Nivalis Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...